Yong Yu
Chief Scientific Officer; SVP, Clinical Development · 5 filings · Latest: Aug 31, 2026
GENELUX Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GNLX | Yong Yu | Chief Scientific Officer | Aug 31, 2026 | Sale | $2.75 | 9,683 | $26.7K | 258,688 | |
GNLX | Yong Yu | Chief Scientific Officer | Aug 4, 2026 | Sale | $2.94 | 653 | $1.9K | 268,371 | |
GNLX | Yong Yu | Chief Scientific Officer | May 11, 2026 | Sale | $2.97 | 605 | $1.8K | 149,706 | |
GNLX | Yong Yu | SVP, Clinical Development | Mar 24, 2026 | Sale | $2.42 | 906 | $2.2K | 144,938 |